PREGABALIN | A211384 | INVAGEN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.0658
per ea
Lowest NADAC/Unit
$0.0428
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 76282057590PREGABALIN 300 MG CAPSULE | $0.0658 | EA | Generic | — | 2026-06-17 |
| 76282057390PREGABALIN 200 MG CAPSULE | $0.0573 | EA | Generic | — | 2026-06-17 |
| 76282057490PREGABALIN 225 MG CAPSULE | $0.0555 | EA | Generic | — | 2026-06-17 |
| 76282057190PREGABALIN 100 MG CAPSULE | $0.0531 | EA | Generic | — | 2026-06-17 |
| 76282057290PREGABALIN 150 MG CAPSULE | $0.0505 | EA | Generic | — | 2026-06-17 |
| 76282057090PREGABALIN 75 MG CAPSULE | $0.0499 | EA | Generic | — | 2026-06-17 |
| 76282056990PREGABALIN 50 MG CAPSULE | $0.0463 | EA | Generic | — | 2026-06-17 |
| 76282056890PREGABALIN 25 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.